Everquest Capital Partners joins Qkine cap table as new shareholder
Published
Cambridge-based Qkine Limited has added Everquest Capital Partners to its shareholder register. Founded in 2016, the company manufactures high-purity, animal-free growth factors and bioactive proteins for applications in stem cell research, regenerative medicine, and cellular agriculture.
According to the latest confirmation statement for the period ending 1 June 2026, Everquest Capital Partners joined the cap table with 18,230 Ordinary shares. The entry introduces a new name to a shareholder list that features several prominent institutional and academic investors.
The Chancellor, Masters and Scholars of the University of Cambridge remains the largest shareholder with 267,317 shares. Other significant holdings are maintained by Martlet Capital Limited with 229,096 shares and the Downing Healthcare Knowledge Intensive EIS Fund with 217,873 shares. Anthemic LLC continues to hold 196,055 shares, while Thames Ventures 2 VCT PLC holds 131,755 shares.
The cap table also includes o2h Nominees Limited with 113,977 shares, KCP Nominees Ltd with 86,956 shares, and CPI Enterprises Ltd with 63,317 shares. International investors Zeppelin Investments Pty Ltd, Aubigny Investments Pty Ltd, and Watson's Bay Investments Pty Ltd also remain on the register. This update confirms the current distribution of equity following the most recent filing period.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| New shareholder | EVERQUEST CAPITAL PARTNERS | 18,230 | — | ORDINARY 18,230 |
Current shareholders (13)
| Shareholder | Total shares | Share classes |
|---|---|---|
| THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE | 267,317 | ORDINARY 267,317 |
| MARTLET CAPITAL LIMITED | 229,096 | ORDINARY 229,096 |
| ANTHEMIC LLC | 221,055 | ORDINARY 221,055 |
| DOWNING HEALTHCARE KNOWLEDGE INTENSIVE EIS FUND | 217,873 | ORDINARY 217,873 |
| O2H NOMINEES LIMITED | 131,835 | ORDINARY 131,835 |
| THAMES VENTURES 2 VCT PLC (DOWNING VCT FUNDS) | 131,755 | ORDINARY 131,755 |
| KCP NOMINEES LTD | 86,956 | ORDINARY 86,956 |
| CPI ENTERPRISES LTD | 63,317 | ORDINARY 63,317 |
| EVERQUEST CAPITAL PARTNERS | 18,230 | ORDINARY 18,230 |
| ZEPPELIN INVESTMENTS PTY LTD | 16,908 | ORDINARY 16,908 |
| DOWNING HEALTHCARE IMPACT EIS FUND | 15,587 | ORDINARY 15,587 |
| AUBIGNY INVESTMENTS PTY LTD | 13,526 | ORDINARY 13,526 |
| WATSON'S BAY INVESTMENTS PTY LTD | 12,077 | ORDINARY 12,077 |
Contact the editorial team at [email protected]